|
See related Lucentis intraocular inj information |
|
|
|
Manufacturer |
Novartis |
|
Distributor |
Hong Kong: Zuellig/Macau: Agencia Lei Va Hong |
|
Contents |
Ranibizumab |
|
Indications |
Treatment of neovascular (wet) age-related macular degeneration.
Click to view Lucentis detailed prescribing infomation |
|
Dosage |
0.5 mg (0.05 mL) by intravitreous inj.
Click to view Lucentis detailed prescribing infomation |
|
Overdosage |
View Lucentis overdosage for action to be taken in the event of an overdose. |
|
Contraindications |
Active or suspected ocular or periocular infections, active intraocular inflammation.
Click to view Lucentis detailed prescribing infomation |
|
Special Precautions |
Observe proper aseptic inj technique. Monitor & manage both IOP & the perfusion of the optic nerve head. May impair ability to drive or operate machinery. Childn & adolescents >18 yr. Pregnancy & lactation.
Click to view Lucentis detailed prescribing infomation |
|
Adverse Drug Reactions |
Headache; conjunctival haemorrhage, eye pain, vitreous floaters, retinal haemorrhage, increased IOP, vitreous detachment, intraocular inflammation, eye irritation, cataract, foreign body sensation in eyes, visual disturbance, blepharitis, subretinal fibrosis, ocular hyperaemia, blurred/decreased visual acuity, dry eye, vitritis, ocular discomfort, conjunctival hyperaemia, posterior capsule opacification, retinal exudates, inj site reactions, increased lacrimation, eye pruritis, conjunctivitis, maculopathy, detachment of the retinal pigment epithelium.
View ADR Monitoring Form |
|
Drug Interactions |
[Click for Lucentis detailed prescribing infomation]
View more drug interactions with Lucentis |
|
Pregnancy Category (US FDA) |
Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus. |
|
Caution For Usage |
For caution against possible variation of physical aspect of medicine... click to view Lucentis detailed prescribing infomation |
|
Description |
View Lucentis description for details of the chemical structure and excipients (inactive components). |
|
Mechanism of Action |
View Lucentis mechanism of action for pharmacodynamics and pharmacokinetics details. |
|
Presentation/Packing |
|
Form |
Packing |
Photo |
|
Lucentis intraocular inj |
|
Lucentis 10 mg/1 mL x 1's |
 |
|
Lucentis 10 mg/1 mL x 0.23 mL x 1's |
|
|
|
Manufacturer: |
Novartis |
|
Distributor: |
Hong Kong: Zuellig
Macau: Agencia Lei Va Hong
|
|
|
|
